To include your compound in the COVID-19 Resource Center, submit it here.

Zovant: Phase III

LLY will report data next month from its international Phase III PROWESS trial of Zovant in 1,690

Read the full 178 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE